MacroGenics
MGNX
MGNX
142 hedge funds and large institutions have $598M invested in MacroGenics in 2023 Q4 according to their latest regulatory filings, with 31 funds opening new positions, 47 increasing their positions, 48 reducing their positions, and 16 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more capital invested
Capital invested by funds: $ → $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
6.6% more ownership
Funds ownership: 93.68% → 100.29% (+6.6%)
2% less repeat investments, than reductions
Existing positions increased: 47 | Existing positions reduced: 48
Holders
142
Holding in Top 10
1
Calls
$295K
Puts
$88K
Top Buyers
| 1 | +$35.7M | |
| 2 | +$8.4M | |
| 3 | +$5.89M | |
| 4 |
FLSM
Frazier Life Sciences Management
Palo Alto,
California
|
+$5.76M |
| 5 |
IHAM
Integral Health Asset Management
New York
|
+$4.33M |
Top Sellers
| 1 | -$11.3M | |
| 2 | -$3.15M | |
| 3 | -$3.02M | |
| 4 |
Jacobs Levy Equity Management
Florham Park,
New Jersey
|
-$2.74M |
| 5 |
AQR Capital Management
Greenwich,
Connecticut
|
-$2M |